Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.
Saved in:
| Title: | Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance. |
|---|---|
| Authors: | Hurley RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., McGehee CD; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Nesic K; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia., Correia C; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Weiskittel TM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Kelly RL; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Venkatachalam A; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Hou X; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA., Pathoulas NM; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905 USA., Meng XW; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Kondrashova O; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia., Radke MR; Department of Obstetrics & Gynecology, University of Washington, Seattle, WA 98195, USA., Schneider PA; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905 USA., Flatten KS; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905 USA., Peterson KL; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905 USA., Becker MA; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA., Wong EM; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Victoria 3800, Australia., Southey MS; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Victoria 3800, Australia., Dobrovic A; University of Melbourne Department of Surgery, Austin Hospital, Heidelberg, Victoria 3084, Australia., Lin KK; Clovis Oncology, San Francisco, CA 94158, USA., Harding TC; Clovis Oncology, San Francisco, CA 94158, USA., McNeish I; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, W12 0NN United Kingdom., Ross CA; Division of Information Technology, Mayo Clinic, Rochester, MN 55905, USA., Wagner JM; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA., Wakefield MJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia., Scott CL; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia., Haluska P; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA., Wahner Hendrickson AE; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA., Karnitz LM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Swisher EM; Department of Obstetrics & Gynecology, University of Washington, Seattle, WA 98195, USA., Li H; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Weroha SJ; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA., Kaufmann SH; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA. |
| Source: | NAR cancer [NAR Cancer] 2021 Jul 09; Vol. 3 (3), pp. zcab028. Date of Electronic Publication: 2021 Jul 09 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34316715 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hurley+RM%22">Hurley RM</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22McGehee+CD%22">McGehee CD</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Nesic+K%22">Nesic K</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.<br /><searchLink fieldCode="AU" term="%22Correia+C%22">Correia C</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Weiskittel+TM%22">Weiskittel TM</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Kelly+RL%22">Kelly RL</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Venkatachalam+A%22">Venkatachalam A</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Hou+X%22">Hou X</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Pathoulas+NM%22">Pathoulas NM</searchLink>; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Meng+XW%22">Meng XW</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Kondrashova+O%22">Kondrashova O</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.<br /><searchLink fieldCode="AU" term="%22Radke+MR%22">Radke MR</searchLink>; Department of Obstetrics & Gynecology, University of Washington, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Schneider+PA%22">Schneider PA</searchLink>; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Flatten+KS%22">Flatten KS</searchLink>; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Peterson+KL%22">Peterson KL</searchLink>; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Becker+MA%22">Becker MA</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Wong+EM%22">Wong EM</searchLink>; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Victoria 3800, Australia.<br /><searchLink fieldCode="AU" term="%22Southey+MS%22">Southey MS</searchLink>; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Victoria 3800, Australia.<br /><searchLink fieldCode="AU" term="%22Dobrovic+A%22">Dobrovic A</searchLink>; University of Melbourne Department of Surgery, Austin Hospital, Heidelberg, Victoria 3084, Australia.<br /><searchLink fieldCode="AU" term="%22Lin+KK%22">Lin KK</searchLink>; Clovis Oncology, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Harding+TC%22">Harding TC</searchLink>; Clovis Oncology, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22McNeish+I%22">McNeish I</searchLink>; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, W12 0NN United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ross+CA%22">Ross CA</searchLink>; Division of Information Technology, Mayo Clinic, Rochester, MN 55905, USA.<br /><searchLink fieldCode="AU" term="%22Wagner+JM%22">Wagner JM</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Wakefield+MJ%22">Wakefield MJ</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.<br /><searchLink fieldCode="AU" term="%22Scott+CL%22">Scott CL</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.<br /><searchLink fieldCode="AU" term="%22Haluska+P%22">Haluska P</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Wahner+Hendrickson+AE%22">Wahner Hendrickson AE</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Karnitz+LM%22">Karnitz LM</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Swisher+EM%22">Swisher EM</searchLink>; Department of Obstetrics & Gynecology, University of Washington, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Weroha+SJ%22">Weroha SJ</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Kaufmann+SH%22">Kaufmann SH</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101769553%22">NAR cancer</searchLink> [NAR Cancer] 2021 Jul 09; Vol. 3 (3), pp. zcab028. <i>Date of Electronic Publication: </i>2021 Jul 09 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769553 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-8674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226328674%22">26328674 </searchLink><i>NLM ISO Abbreviation: </i>NAR Cancer <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34316715 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/narcan/zcab028 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: zcab028 Titles: – TitleFull: Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hurley RM – PersonEntity: Name: NameFull: McGehee CD – PersonEntity: Name: NameFull: Nesic K – PersonEntity: Name: NameFull: Correia C – PersonEntity: Name: NameFull: Weiskittel TM – PersonEntity: Name: NameFull: Kelly RL – PersonEntity: Name: NameFull: Venkatachalam A – PersonEntity: Name: NameFull: Hou X – PersonEntity: Name: NameFull: Pathoulas NM – PersonEntity: Name: NameFull: Meng XW – PersonEntity: Name: NameFull: Kondrashova O – PersonEntity: Name: NameFull: Radke MR – PersonEntity: Name: NameFull: Schneider PA – PersonEntity: Name: NameFull: Flatten KS – PersonEntity: Name: NameFull: Peterson KL – PersonEntity: Name: NameFull: Becker MA – PersonEntity: Name: NameFull: Wong EM – PersonEntity: Name: NameFull: Southey MS – PersonEntity: Name: NameFull: Dobrovic A – PersonEntity: Name: NameFull: Lin KK – PersonEntity: Name: NameFull: Harding TC – PersonEntity: Name: NameFull: McNeish I – PersonEntity: Name: NameFull: Ross CA – PersonEntity: Name: NameFull: Wagner JM – PersonEntity: Name: NameFull: Wakefield MJ – PersonEntity: Name: NameFull: Scott CL – PersonEntity: Name: NameFull: Haluska P – PersonEntity: Name: NameFull: Wahner Hendrickson AE – PersonEntity: Name: NameFull: Karnitz LM – PersonEntity: Name: NameFull: Swisher EM – PersonEntity: Name: NameFull: Li H – PersonEntity: Name: NameFull: Weroha SJ – PersonEntity: Name: NameFull: Kaufmann SH IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 07 Text: 2021 Jul 09 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2632-8674 Numbering: – Type: volume Value: 3 – Type: issue Value: 3 Titles: – TitleFull: NAR cancer Type: main |
| ResultId | 1 |